5 Key Takeaways
-
1
Stephen Guilfoyle discusses the regulatory landscape regarding leachable pharmaceutical impurities.
-
2
Thermo Fisher Scientific offers a broad portfolio of tools for Extractables & Leachables testing.
-
3
The article highlights the importance of addressing challenges related to pharmaceutical impurities.
-
4
Developments in regulations are influencing the approach to leachable impurities in pharmaceuticals.
-
5
The full analytical portfolio aims to support compliance and testing in the pharmaceutical industry.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.